GR3036570T3 - 6-Azaindole thromboxane synthase inhibitors. - Google Patents

6-Azaindole thromboxane synthase inhibitors.

Info

Publication number
GR3036570T3
GR3036570T3 GR20010401424T GR20010401424T GR3036570T3 GR 3036570 T3 GR3036570 T3 GR 3036570T3 GR 20010401424 T GR20010401424 T GR 20010401424T GR 20010401424 T GR20010401424 T GR 20010401424T GR 3036570 T3 GR3036570 T3 GR 3036570T3
Authority
GR
Greece
Prior art keywords
azaindole
synthase inhibitors
thromboxane synthase
integer
zero
Prior art date
Application number
GR20010401424T
Other languages
English (en)
Inventor
Joseph Anthony Jakubowski
Alan David Palkowitz
Sandra Kay Sigmund
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR3036570T3 publication Critical patent/GR3036570T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR20010401424T 1994-01-31 2001-09-07 6-Azaindole thromboxane synthase inhibitors. GR3036570T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/189,212 US5468757A (en) 1994-01-31 1994-01-31 6-azaindole thromboxane synthase inhibitors

Publications (1)

Publication Number Publication Date
GR3036570T3 true GR3036570T3 (en) 2001-12-31

Family

ID=22696403

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401424T GR3036570T3 (en) 1994-01-31 2001-09-07 6-Azaindole thromboxane synthase inhibitors.

Country Status (11)

Country Link
US (1) US5468757A (el)
EP (1) EP0668279B1 (el)
JP (1) JPH0853448A (el)
AT (1) ATE202103T1 (el)
CA (1) CA2141231A1 (el)
DE (1) DE69521223T2 (el)
DK (1) DK0668279T3 (el)
ES (1) ES2157292T3 (el)
GR (1) GR3036570T3 (el)
PT (1) PT668279E (el)
SI (1) SI0668279T1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2677910C (en) * 1997-10-17 2011-03-15 Ark Therapeutics Limited The use of inhibitors of the renin-angiotensin system for the treatment of cardiovascular diseases
DE69824029T2 (de) 1997-10-20 2005-05-12 F. Hoffmann-La Roche Ag Bicyclische kinase inhibitoren
ATE258934T1 (de) 1998-10-30 2004-02-15 Lilly Co Eli Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
CA2367121A1 (en) * 1999-03-10 2000-09-14 Merck & Co., Inc. 6-azaindole compounds as antagonists of gonadotropin releasing hormone
US20040235867A1 (en) * 2001-07-24 2004-11-25 Bilodeau Mark T. Tyrosine kinase inhibitors
GB0330043D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
BRPI0511874A (pt) 2004-06-09 2008-01-15 Glaxo Group Ltd derivados da pirrolopiridina
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
MA52809A (fr) * 2018-06-07 2021-04-14 Disarm Therapeutics Inc Inhibiteurs de sarm1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1250844A (en) * 1981-06-22 1989-03-07 Neville Ford Substituted imidazo¬1,5-a|pyridines, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic application
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
DE3302125A1 (de) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung
FR2658511B1 (fr) * 1990-02-16 1992-06-19 Union Pharma Scient Appl Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant.
EP0530579B1 (en) * 1991-08-21 1998-11-11 Eisai Co., Ltd. Condensed pyrimidine derivatives antitumor agents

Also Published As

Publication number Publication date
DE69521223D1 (de) 2001-07-19
DK0668279T3 (da) 2001-08-27
JPH0853448A (ja) 1996-02-27
EP0668279A3 (en) 1995-08-30
PT668279E (pt) 2001-09-28
EP0668279A2 (en) 1995-08-23
EP0668279B1 (en) 2001-06-13
CA2141231A1 (en) 1995-08-01
DE69521223T2 (de) 2001-11-08
ES2157292T3 (es) 2001-08-16
US5468757A (en) 1995-11-21
SI0668279T1 (en) 2001-12-31
ATE202103T1 (de) 2001-06-15

Similar Documents

Publication Publication Date Title
ES2090790T3 (es) Derivados de glicolipidos.
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
GR3036570T3 (en) 6-Azaindole thromboxane synthase inhibitors.
ATE232528T1 (de) Pyrimidinylpyrazolderivate
PT947504E (pt) Derivados de vitamina d 16-eno
ES2188481T3 (es) Derivados de polinalbufina.
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
EP0601191A4 (en) Novel tetracyclic compound.
FI900796A0 (fi) Aralkylaminfoereningar.
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
HU9600996D0 (en) Nitric esters from derivatives of 2-(2,6-dihalophenyl-amino)-phenylacetoxyacetic acid and their preparation procedures
BG103398A (en) New derivatives of erythromicyn, method for their preparation and application as medicmentous forms
SI0681788T1 (en) Dioxabicyclo(3.3.0) octane derivatives, e.g. sesamin etc., for prevention or alleviation of allergy symptoms
DE69805267T2 (de) Cyclopropancyclus enthaltende Purinderivate
DK1264836T3 (da) Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater
EP0418655A3 (en) Conjugated gamma-hydroxybutenolide compounds and antiulcer agents containing the same as an effective ingredient
EP1466900A4 (en) DERIVATIVES OF VITAMIN D-DOUBLE SUBSTITUTION
MX9703497A (es) Derivados del acido 2[ (2-alcoxi-6-trifluorometilpirimidin-4-il)oximetilen]-fenilacetico, su preparacion, intermediarios y usos de este.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees